Early cancer screening can play a transformative role in healthcare, potentially saving lives by identifying cancer before it progresses to an advanced, less treatable stage. However, designing ...

Personalized Chemotherapy on the Basis of Tumor Marker Decline in Poor-Prognosis Germ-Cell Tumors: Updated Analysis of the GETUG-13 Phase III Trial Earlier detection of cancer offers an opportunity to ...

About The Study: In this systematic review and meta-analysis that included 41 randomized clinical trials of cancer screening, incidence of late-stage cancer may be a suitable alternative end point to ...

HealthDay News — Compared with manual screening, an artificial intelligence (AI)-assisted patient screening tool can improve the rate of eligibility determination and enrollment for randomized ...

Composite endpoints are widely used in large randomised cardiovascular outcome trials. They are frequently referred to as ...

A pioneering study has found that an individualized approach to breast cancer screening that assesses patients' risk, rather ...

Note: This is the third article of a three-part series. Real-world evidence (RWE) plays a crucial role in supporting the benefits of one drug over another in debates that play out on the boards and ...

Mass General Brigham has announced the development of an AI company and screening tool that has sped up the process for determining a patient’s eligibility and enrollment for clinical trials.

Background Although multiple studies have offered self-collection for human papillomavirus (HPV)-based cervical screening in ...